Overview
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is the enveloped, positive-sense single-stranded RNA betacoronavirus that causes coronavirus disease 2019 (COVID-19), first identified in late 2019 and subsequently declared a global pandemic. It belongs to the family Coronaviridae and is closely related to the earlier SARS-CoV, sharing the characteristic crown-like array of surface spike (S) glycoproteins from which coronaviruses take their name. The spike protein mediates attachment to and entry into host cells and is a primary focus of vaccine and therapeutic development. The virus spreads chiefly through respiratory droplets and aerosols, and infection ranges from asymptomatic carriage to severe pneumonia and multi-organ involvement. Research on SARS-CoV-2 spans its molecular evolution and phylogenetic relationship to other human and animal coronaviruses through spike gene sequence analysis, the prediction and tracking of viral mutations, viral kinetics under candidate treatments, host immune and cytokine responses to the spike protein, transmissibility modelling across interacting populations, vaccination outcomes and adverse events, and convalescent-plasma neutralizing antibody approaches. The journal also publishes on the cellular pathogenesis of infected tissues, the zoonotic dimension linking animals to human infection, and candidate prophylactic and therapeutic strategies, reflecting the breadth of virological, clinical, and epidemiological study the topic encompasses.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
SARS-Cov-2 Viral Kinetics in Mild COVID-19 Patients Treated with Chloroquine Regimens or Standard of Care
SARS-CoV-2 affected cells Pathogeny and Therapy
Marginal SARS-CoV-2 Spike Protein Increases Interferon and Balances Cytokine Gene Expression
Pyrexia And Liver Injury After A Second SARS-CoV-2 Vaccination: Macrophage Activation Manifested In Liver
Presentation of Neutralizing Antibodies in Single- or Pooled-Convalescent Immune Plasma from Donors to Prevent the Current SARS-CoV-2 Pandemic
An Algorithm to Predict the Possible SARS-CoV-2 Mutations
Analytical Solutions of the Transmissibility of the SARS-CoV-2 in Three Interactive Populations
The Novel Coronavirus 2019 (COVID-19): A Narrative Review
Animals in the COVID-19 Era: Between Being a source, Victims, or Maybe our Hope to Overcome it!
Reducing COVID-19 Risk through Dietary Supplementation of Plant Mannose Binding Lectins
SARS-Corona Virus-2 Origin and Treatment, From Coffee to Coffee: A Double-Edged Sword
How this research is being cited
The 12 articles above have been cited 24 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2024 · German Journal of Pharmaceuticals and Biomaterials
-
2023 · Research Square (Research Square)
-
2023 · Journal of Model Based Research
-
2023 · Revista Brasileira de Farmacognosia
-
2023 · Revista Brasileira de Farmacognosia
-
2023 · Journal of Model Based Research
-
Satadal Das et al. · 2023 · International Journal of Applied Biology
-
2023 · Applied Mathematics and Nonlinear Sciences
A sample of recent works citing this journal's research on SARS-CoV-2, linking to each citing work.